FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076277146> ?p ?o ?g. }

• W2076277146 endingPage "620" @default.
• W2076277146 startingPage "615" @default.
• W2076277146 abstract "In this article, the authors intend to provide an update on clinical trials of pharmacologic prevention of restenosis after percutaneous coronary interventions, placed in the perspective of the use of orally administered therapy for the prevention of atherosclerosis progression and clinical events.AGI-1067, the mono-succinic acid ester of probucol, is a phenolic antioxidant member of a novel class of agents termed v-protectants. It has strong antioxidant properties equipotent to those of probucol and antiinflammatory properties. It inhibits gene expression of VCAM-1 and MCP-1 and has been effective at preventing atherosclerosis in all tested animal models including the non-human primate. In the Canadian Antioxidant Restenosis Trial (CART) 1, AGI-1067 and probucol improved lumen dimensions at the site of percutaneous coronary intervention. AGI-1067 also improved luminal dimensions of non-intervened coronary reference segments in the Canadian Antioxidant Restenosis Trial, which suggests a direct antiatherosclerosis effect. Probucol reduced post-percutaneous coronary intervention restenosis and progression of carotid atherosclerosis in other clinical trials. Although statins reduce atherosclerotic events, they do not appear to have a significant effect on restenosis. The failure of folate therapy to protect against restenosis in the Folate After Coronary Intervention Trial (FACIT) occurred despite significant reductions in homocysteine levels.Prevention of both post-percutaneous coronary intervention restenosis and atherosclerosis progression with a pharmacologic agent such as AGI-1067 may be an attractive treatment paradigm. Two important trials that test the antioxidant/antiinflammatory hypothesis are ongoing with AGI-1067: the Canadian Atherosclerosis and Restenosis Trial 2, which assesses its value for the reduction of both atherosclerosis progression and post-percutaneous coronary interventions restenosis, and the Aggressive Reduction of Inflammation Stops Events (ARISE) trial which is evaluating its effects on cardiovascular events." @default.
• W2076277146 created "2016-06-24" @default.
• W2076277146 creator A5031121550 @default.
• W2076277146 creator A5037522111 @default.
• W2076277146 creator A5049309607 @default.
• W2076277146 creator A5074534663 @default.
• W2076277146 date "2003-12-01" @default.
• W2076277146 modified "2023-10-18" @default.
• W2076277146 title "Pharmacologic prevention of both restenosis and atherosclerosis progression: AGI-1067, probucol, statins, folic acid and other therapies" @default.
• W2076277146 cites W1526223266 @default.
• W2076277146 cites W1562133246 @default.
• W2076277146 cites W1615204170 @default.
• W2076277146 cites W1778548343 @default.
• W2076277146 cites W18416084 @default.
• W2076277146 cites W1853891275 @default.
• W2076277146 cites W1963804628 @default.
• W2076277146 cites W1973429676 @default.
• W2076277146 cites W1981882003 @default.
• W2076277146 cites W1987634415 @default.
• W2076277146 cites W1992310702 @default.
• W2076277146 cites W1994492137 @default.
• W2076277146 cites W1995175728 @default.
• W2076277146 cites W2002174152 @default.
• W2076277146 cites W2014429064 @default.
• W2076277146 cites W2015323294 @default.
• W2076277146 cites W2022075810 @default.
• W2076277146 cites W2022922511 @default.
• W2076277146 cites W2023589885 @default.
• W2076277146 cites W2024190102 @default.
• W2076277146 cites W2031093055 @default.
• W2076277146 cites W2032084625 @default.
• W2076277146 cites W2058084355 @default.
• W2076277146 cites W2060644706 @default.
• W2076277146 cites W2064823288 @default.
• W2076277146 cites W2065154595 @default.
• W2076277146 cites W2067088659 @default.
• W2076277146 cites W2068537121 @default.
• W2076277146 cites W2069972750 @default.
• W2076277146 cites W2075128270 @default.
• W2076277146 cites W2093019635 @default.
• W2076277146 cites W2098091709 @default.
• W2076277146 cites W2104873836 @default.
• W2076277146 cites W2109098768 @default.
• W2076277146 cites W2110165404 @default.
• W2076277146 cites W2111737347 @default.
• W2076277146 cites W2111779767 @default.
• W2076277146 cites W2115415893 @default.
• W2076277146 cites W2118667643 @default.
• W2076277146 cites W2124547521 @default.
• W2076277146 cites W2134919787 @default.
• W2076277146 cites W2139018594 @default.
• W2076277146 cites W2140393634 @default.
• W2076277146 cites W2144153470 @default.
• W2076277146 cites W2146960356 @default.
• W2076277146 cites W2154283765 @default.
• W2076277146 cites W2154286360 @default.
• W2076277146 cites W2155372623 @default.
• W2076277146 cites W2159111147 @default.
• W2076277146 cites W2162687910 @default.
• W2076277146 cites W2168582542 @default.
• W2076277146 cites W2178344076 @default.
• W2076277146 cites W2315170757 @default.
• W2076277146 cites W2315618879 @default.
• W2076277146 cites W2330609598 @default.
• W2076277146 cites W2341744705 @default.
• W2076277146 cites W2345529011 @default.
• W2076277146 cites W4234610775 @default.
• W2076277146 doi "https://doi.org/10.1097/00041433-200312000-00010" @default.
• W2076277146 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14624139" @default.
• W2076277146 hasPublicationYear "2003" @default.
• W2076277146 type Work @default.
• W2076277146 sameAs 2076277146 @default.
• W2076277146 citedByCount "15" @default.
• W2076277146 countsByYear W20762771462014 @default.
• W2076277146 countsByYear W20762771462016 @default.
• W2076277146 countsByYear W20762771462021 @default.
• W2076277146 crossrefType "journal-article" @default.
• W2076277146 hasAuthorship W2076277146A5031121550 @default.
• W2076277146 hasAuthorship W2076277146A5037522111 @default.
• W2076277146 hasAuthorship W2076277146A5049309607 @default.
• W2076277146 hasAuthorship W2076277146A5074534663 @default.
• W2076277146 hasConcept C126322002 @default.
• W2076277146 hasConcept C164705383 @default.
• W2076277146 hasConcept C2776167589 @default.
• W2076277146 hasConcept C2778163477 @default.
• W2076277146 hasConcept C2778213512 @default.
• W2076277146 hasConcept C2778283817 @default.
• W2076277146 hasConcept C2778583881 @default.
• W2076277146 hasConcept C2780400711 @default.
• W2076277146 hasConcept C2991716557 @default.
• W2076277146 hasConcept C500558357 @default.
• W2076277146 hasConcept C535046627 @default.
• W2076277146 hasConcept C71924100 @default.
• W2076277146 hasConceptScore W2076277146C126322002 @default.
• W2076277146 hasConceptScore W2076277146C164705383 @default.
• W2076277146 hasConceptScore W2076277146C2776167589 @default.
• W2076277146 hasConceptScore W2076277146C2778163477 @default.
• W2076277146 hasConceptScore W2076277146C2778213512 @default.

• next